Advertisement

Topics

Emmaus Life Sciences, Inc. Company Profile

02:24 EST 14th December 2018 | BioPortfolio

Emmaus Life Sciences is dedicated to the discovery, development and commercialization of innovative treatments and therapies for rare diseases. The Company’s research on sickle cell disease and sickle beta-0 thalassemia was initiated by Dr. Niihara at the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center. The therapy has Orphan Drug designation in the U.S. and Europe and Fast Track designation from the FDA.


News Articles [2012 Associated News Articles listed on BioPortfolio]

Emmaus Life Sciences to Participate in the Piper Jaffray Healthcare Conference

Emmaus Life Sciences, Inc. (Emmaus), a leader in sickle cell disease treatment, announced today that its CEO, Yutaka Niihara, MD, MPH will present at the 30th Annual&#...

Emmaus Life Sciences to Participate in the Cantor Global Healthcare Conference

Emmaus Life Sciences, Inc. (Emmaus), a leader in sickle cell disease treatment, announced today that Kurt Kruger, Chief Financial Officer, will present at the 2018...

Emmaus Signs Agreement with Cardinal Health to Solidify Distribution Network for Endari

News Endari (L-glutamine oral powder) is indicated to reduce the acute complications of sickle cell disease in adult and pediatric patients five years of age and older.

Emmaus Signs Agreement with McKesson to Expand Endari Distribution Network

NewsThe agreement makes Endari indicated to reduce the acute complications of sickle cell disease in patients five years and older, available nationwide to pharmacies that utilize McKesson as their pr...

Emmaus Life Sciences Announces FDA Acceptance of IND Application for Clinical Study of L-glutamine for Treatment of Diverticulosis

Emmaus Life Sciences (Emmaus), a biopharmaceutical company based in Torrance, California, today announced that the U.S. Food and Drug Administration has accepted its Investigation...

Emmaus Life Sciences Names LaVoieHealthScience as Strategic Communications Agency of Record

LaVoieHealthScience (LHS), an integrated investor and public relations agency focused on advancing health and science innovations, today announced that it has added Emmaus ...

A bigger, better Office for Life Sciences

The Department for Business, Innovation and Skills (BIS) and the Department of Health (DH) are joining their life sciences functions to create a new, expanded Office for Life Sciences.BIS and DH have ...

Emmaus Life Sciences Announces Presentation of Abstract at the 2018 American Society of Hematology Annual Meeting

Emmaus Life Sciences, Inc. (Emmaus), a leader in sickle cell disease treatment, announced today that its abstract has been accepted for poster presentation at the American ...

PubMed Articles [2810 Associated PubMed Articles listed on BioPortfolio]

Systemic and Reflexive: Foundations of Cumulative Dis/Advantage and Life-Course Processes.

Post-Retirement Life Satisfaction and Financial Vulnerability: The Moderating Role of Control.

This paper examines changes in life satisfaction around retirement exits for those with varying pre-retirement incomes, testing whether constraints on control and control over finances moderate the re...

Early-Life Adversity and Dysregulation of Adult Diurnal Cortisol Rhythm.

Exposure to life stresses can lead to diminution in the capacity of stress response systems to mount a robust response to new challenges, with blunting of dynamic range - the spread between maximal at...

Early-Life Military Exposures and Functional Impairment Trajectories Among Older Male Veterans: The Buffering Effect of Psychological Resilience.

Drawing on the life course framework and theoretical concept of resilience, we examine the impact of early-life service-related exposures (SREs) on later-life functional impairment trajectories among ...

Late-life depressive symptoms are associated with functional impairment cross-sectionally and over time: Results of the AgeMooDe study.

This study examines the relationship between late-life depressive symptoms, cognitive and functional impairment in a cohort of very old community-based participants.

Clinical Trials [2270 Associated Clinical Trials listed on BioPortfolio]

Advance Care Planning at London Health Sciences Centre

All patients admitted to London Health Sciences Centre (LHSC) are asked to indicate their preferences for CPR (cardiopulmonary resuscitation) and other life-sustaining treatments that nece...

M-learning to Improve Professional Competencies in Health Sciences

The aim of this study is to investigate whether a mobile application is useful for improving knowledge about professional competencies in students enrolled in Health Sciences degrees.

Assessment of the Burden Within the Dyad Patient/Caregiver

This study is about the patients life ending and their caregiver, when a return to home is planned. This is a behavioral sciences study (= interventional study for french law)

Cognitive Rehabilitation With C8 Sciences

C8 sciences program is a cognitive training program mainly developed for the students, and the effectiveness is well established. The aim of this trial is to assess clinical efficacy of th...

A Study of Sofosbuvir From Heterosofir 400 mg F.C.T (Pharmed Healthcare, Egypt) & Sovaldi 400 mg F.C.T ( Gilead Sciences, Ireland)

Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Sofosbuvir from Heterosofir 400 mg F.C.T (Pharmed Healthcare Co., Egypt) versus S...

Companies [2025 Associated Companies listed on BioPortfolio]

Emmaus Life Sciences, Inc.

Emmaus Life Sciences is dedicated to the discovery, development and commercialization of innovative treatments and therapies for rare diseases. The Company’s research on sick...

Life Sciences Pennsylvania

Life Sciences Pennsylvania is the statewide trade association for the life sciences in Pennsylvania and serves as a catalyst to ensure Pennsylvania is a global leader in the life ...

Emmaus Medical, Inc.

Central Life Sciences

Central Life Sciences is a strategic business unit of Central Garden & Pet (NASDAQ: CENT). Central Life Sciences is dedicated to creating healthier environments and making life better for people, ...

California Life Sciences Institute

California Life Sciences Institute (CLSI) supports the foundations of innovation that have made California home to the world’s most prominent life sciences ecosystem. With a ...

More Information about "Emmaus Life Sciences, Inc." on BioPortfolio

We have published hundreds of Emmaus Life Sciences, Inc. news stories on BioPortfolio along with dozens of Emmaus Life Sciences, Inc. Clinical Trials and PubMed Articles about Emmaus Life Sciences, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Emmaus Life Sciences, Inc. Companies in our database. You can also find out about relevant Emmaus Life Sciences, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...


Corporate Database Quicklinks



Searches Linking to this Company Record